Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement.

× No keyword cloud information.

13 in total

1. Impact of oxaliplatin-induced neuropathy: a patient perspective.

Authors: Barbara K Bennett; Susanna B Park; Cindy S-Y Lin; Michael L Friedlander; Matthew C Kiernan; David Goldstein
Journal: Support Care Cancer Date: 2012-03-17 Impact factor: 3.603

2. Chemotherapy-Induced Peripheral Neuropathy in Pediatric Cancer Patients.

Authors: Rhonda J Moore; Hunter Groninger
Journal: Cureus Date: 2013-06-14

3. Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice.

Authors: S Vasquez; M Guidon; E McHugh; O Lennon; L Grogan; O S Breathnach
Journal: Ir J Med Sci Date: 2013-07-07 Impact factor: 1.568

4. Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors.

Authors: Cindy Tofthagen; Kristine A Donovan; Mary Ann Morgan; David Shibata; Yating Yeh
Journal: Support Care Cancer Date: 2013-08-01 Impact factor: 3.603

5. Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients.

Authors: Rebecca M Speck; Angela DeMichele; John T Farrar; Sean Hennessy; Jun J Mao; Margaret G Stineman; Frances K Barg
Journal: Support Care Cancer Date: 2012-01-11 Impact factor: 3.603

6. Falls in persons with chemotherapy-induced peripheral neuropathy.

Authors: Cindy Tofthagen; Janine Overcash; Kevin Kip
Journal: Support Care Cancer Date: 2011-03-05 Impact factor: 3.603

Review 7. Platinum neurotoxicity pharmacogenetics.

Authors: Sarah R McWhinney; Richard M Goldberg; Howard L McLeod
Journal: Mol Cancer Ther Date: 2009-01 Impact factor: 6.261

8. Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients.

Authors: Heshan Liu; Angelina D Tan; Rui Qin; Daniel J Sargent; Axel Grothey; Jan C Buckner; Paul L Schaefer; Jeff A Sloan
Journal: SOJ Anesthesiol Pain Manag Date: 2015-04-10

9. Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer.

Authors: Crystal T Pike; Howard G Birnbaum; Catherine E Muehlenbein; Gerhardt M Pohl; Ronald B Natale
Journal: Chemother Res Pract Date: 2012-03-14

10. P2X7 Cell Death Receptor Activation and Mitochondrial Impairment in Oxaliplatin-Induced Apoptosis and Neuronal Injury: Cellular Mechanisms and In Vivo Approach.

Authors: France Massicot; Guillaume Hache; Ludivine David; Dominique Chen; Charlotte Leuxe; Laure Garnier-Legrand; Patrice Rat; Olivier Laprévote; François Coudoré
Journal: PLoS One Date: 2013-06-27 Impact factor: 3.240